IMMP
Price
$1.60
Change
-$0.01 (-0.62%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
222.56M
67 days until earnings call
SMMT
Price
$20.57
Change
+$0.41 (+2.03%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
15.26B
46 days until earnings call
Interact to see
Advertisement

IMMP vs SMMT

Header iconIMMP vs SMMT Comparison
Open Charts IMMP vs SMMTBanner chart's image
Immutep
Price$1.60
Change-$0.01 (-0.62%)
Volume$13.85K
Capitalization222.56M
Summit Therapeutics
Price$20.57
Change+$0.41 (+2.03%)
Volume$51.01K
Capitalization15.26B
IMMP vs SMMT Comparison Chart in %
Loading...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMP vs. SMMT commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMP is a Hold and SMMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (IMMP: $1.60 vs. SMMT: $20.55)
Brand notoriety: IMMP and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMP: 35% vs. SMMT: 58%
Market capitalization -- IMMP: $222.56M vs. SMMT: $15.26B
IMMP [@Biotechnology] is valued at $222.56M. SMMT’s [@Biotechnology] market capitalization is $15.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMT’s FA Score shows that 1 FA rating(s) are green whileIMMP’s FA Score has 0 green FA rating(s).

  • SMMT’s FA Score: 1 green, 4 red.
  • IMMP’s FA Score: 0 green, 5 red.
According to our system of comparison, SMMT is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMP’s TA Score shows that 3 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • IMMP’s TA Score: 3 bullish, 6 bearish.
  • SMMT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than IMMP.

Price Growth

IMMP (@Biotechnology) experienced а -8.05% price change this week, while SMMT (@Biotechnology) price change was +3.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

Reported Earning Dates

IMMP is expected to report earnings on Aug 27, 2025.

SMMT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($15.3B) has a higher market cap than IMMP($223M). SMMT YTD gains are higher at: 15.158 vs. IMMP (-26.267). IMMP has higher annual earnings (EBITDA): -43.83M vs. SMMT (-235.08M). SMMT has more cash in the bank: 361M vs. IMMP (159M). IMMP has less debt than SMMT: IMMP (1.69M) vs SMMT (6.45M). IMMP (0) and SMMT (0) have equivalent revenues.
IMMPSMMTIMMP / SMMT
Capitalization223M15.3B1%
EBITDA-43.83M-235.08M19%
Gain YTD-26.26715.158-173%
P/E RatioN/A26.36-
Revenue00-
Total Cash159M361M44%
Total Debt1.69M6.45M26%
FUNDAMENTALS RATINGS
SMMT vs IMMP: Fundamental Ratings
SMMT
IMMP
OUTLOOK RATING
1..100
1451
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
4589
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4388
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMMP's Valuation (83) in the Biotechnology industry is in the same range as SMMT (95). This means that IMMP’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (45) in the Biotechnology industry is somewhat better than the same rating for IMMP (89). This means that SMMT’s stock grew somewhat faster than IMMP’s over the last 12 months.

IMMP's SMR Rating (96) in the Biotechnology industry is in the same range as SMMT (98). This means that IMMP’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for IMMP (88). This means that SMMT’s stock grew somewhat faster than IMMP’s over the last 12 months.

SMMT's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for IMMP (100). This means that SMMT’s stock grew significantly faster than IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMMPSMMT
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 19 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNBIX19.80N/A
N/A
Manning & Napier Pro-Blend Extnd Term I
DASCX17.38N/A
N/A
Dean Small Cap Value
ISTIX76.99N/A
N/A
Macquarie Science and Technology I
WICVX9.25N/A
N/A
Wasatch Small Cap Value Institutional
RPNIX10.47N/A
N/A
Riverpark/Next Century Gr Inst

IMMP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
-0.62%
PRRUF - IMMP
43%
Loosely correlated
N/A
CALC - IMMP
39%
Loosely correlated
-2.96%
BCRX - IMMP
33%
Poorly correlated
+1.41%
ARCT - IMMP
31%
Poorly correlated
-0.32%
AXON - IMMP
31%
Poorly correlated
+0.85%
More

SMMT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+1.93%
BCDA - SMMT
70%
Closely correlated
-0.94%
TIL - SMMT
52%
Loosely correlated
-3.99%
BNTX - SMMT
50%
Loosely correlated
+2.04%
RLAY - SMMT
46%
Loosely correlated
-5.51%
VBIZF - SMMT
42%
Loosely correlated
N/A
More